Connecting the scientific community and patient care to advance haematopoietic cell transplantation and cellular therapies. Improving lives worldwide. 🌎
Have a challenging IEI case to discuss?
➡️Submit your paediatric or young adult case for the next IEWP Live Forum Session and benefit from expert discussion on complex HCT decision-making.
📅 Case submisison deadline: 17 August
🗓️ Next session: 1 September | 16:00–17:00 CEST
🔗 Learn more, register and share your case: https://t.co/tgIyehc7Ci
#HCT #InbornErrors #liveforum #pediatrics #CellTherapy
📣 Master survival analysis and join a practical four-day course to build your statistical skills with expert guidance, specially designed for clinicians and data managers. 🐦 Early Bird rate available until 10 August.
🗓️ 19–22 October
📍 Leiden, Netherlands
Spots are limited, book yours today➡️ https://t.co/OEj8FRrkHt
#survivalanalysis #datacollection #statistics #educationalcourse
📘 The 52nd Annual Meeting of the EBMT Abstract Book is now available @BMTjournal!
Discover the latest scientific breakthroughs, explore cutting-edge research, and browse all presented abstracts from the meeting.
🔗 Read it now: https://t.co/Nd1IDd8gzE
#EBMT26#Hematology #CellTherapy #StemCellTransplantation #ScientificResearch #MedicalInnovation
🗣️ Submit your case for the Educational Course on Infections and Complications After Stem Cell Transplantation and CAR T-cell Therapy.📍Madrid, Spain 📅 19-21 November
✈️ Travel Grants available!
Learn more ➡️ https://t.co/JquUCJQKT1
#HCT#celltherapy#casesubmission #educationalmeeting
📅 Join the next Inborn Errors WP Live Forum Session on 4 August!
Take part in interactive discussions on challenging IEI cases and hear perspectives on HCT decision-making. 🖥️ Register today: https://t.co/tgIyehc7Ci
The sharing of collective experience, expert opinion, and practical insight is essential for improving patient care and advancing the field.
#HCT #CellTherapy #InbornErrors #MedicalEducation
🔖Discover the Editors’ Picks from @BMTjournal: essential new EBMT guidelines, clinical insights, and abstracts from our 52nd Annual Meeting. Advance your practice—read the latest now.
https://t.co/s2LxwuZ4nM
#EBMT#Transplantation#CellTherapy
New study from the ALWP/EBMT: in secondary AML transplanted in CR1 with PTCy-based GVHD prophylaxis, haploidentical and 9/10 mismatched unrelated donors showed comparable relapse, NRM and survival
https://t.co/lSKQNpkfCx
📚 Looking to expand your knowledge in #HCT and #CellTherapy?
Get inspired after summer and explore our upcoming educational meetings, connect with leading experts, and stay up to date with the latest advances in the field: 🔗 https://t.co/aOS1xaKyiM
#hematology #transplantation #patientcare #medicaleducation
🗣️ Explore the latest in sickle cell disease and thalassaemia; from pathophysiology to cutting-edge treatments.
Save your seat at the Early Bird price until 3 August and join leading experts in Regensburg in September ➡️ https://t.co/zp8fzmKw6G
💡 Now in its 8th edition, this meeting has become a well-established and highly valued event in the field of haemoglobinopathies.
#thalassemia #sicklecelldisease #patientcare
Join the Inborn Errors Working Party Live Forum Session on IEI on 4 August, 16:00–17:00 CEST.
Chaired by Dr. Claire Booth, this webinar will feature expert case discussions on immune-mediated thrombocytopenia after allogeneic HCT and advanced CVID with combined immunodeficiency in adulthood.
➡️Register now: https://t.co/qXZAB5SjmX
#HCT #PatientCare #ClinicalCase #InbornErrors
📰 Check out the Paper of the Month - CAR T Outcomes Begin Before Infusion
🔎 What factors influence outcomes after second-line CAR-T therapy for relapsed/refractory large B-cell lymphoma? 🔗: https://t.co/R2Pn3ZiLh3
#scientificpublication#lymphoma#medicaleducation#CARTcell #celltherapy
📣 Present your work and submit you case by 20 July! 📩
Join us for an interactive hands-on meeting on transplant and cellular immunotherapy for lymphoma and novel indications in 📍 Heidelberg in October.
Learn more, apply for a grant and submit your work ➡️ https://t.co/vthiBri7dM
#lymphoma #clinicalcase #HCT #celltherapy #immunotherapy
🧬 Managing a complex case of an inborn error of immunity?
Submit your work to the next IEWP Live Forum and join expert-led discussions on HCT indication, timing, donor selection and more ➡️ https://t.co/FJMQyC2M4i
#HCT#PatientCare#InbornErrors#FreeWebinar
🔎 Our latest Clinical Case of the Month presents a patient with classical chronic phase CML (chronic myeloid leukaemia). Have a look and learn more in the expert review ➡️ https://t.co/IVABUnPYtK
#leukemia#HCT#ClinicalCase
#Hematology Autologous and allogeneic haematopoietic cell transplantation in adult patients with #Hodgkin#lymphoma: recommendations from the @TheEBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party #lymsm#bmtsm https://t.co/MDsyYG7vV1
Prunotto, Lucchini et al describe clinical presentation, immunological status, treatment, & long-term outcomes of a large cohort of pediatric and adult patients affected by an extremely complex and rare immunodeficiency known as #TTC7A deficiency. https://t.co/8ExyJHowTZ
@TheEBMT